RCT: Tezepelumab can reduce exacerbations in adults and adolescents with severe, uncontrolled asthma.
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma – New England Journal of Medicine Commentary: New drug shows promise against tough-to-manage asthma – MedicalXpress
The post RCT: Tezepelumab can reduce exacerbations in adults and adolescents with severe, uncontrolled asthma. appeared first on Links Medicus.
[Preprint] The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries.
The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries – The Lancet
The post [Preprint] The Emergence of COVID-19 Associated Mucormycosis: Analysis of Cases From 18 Countries. appeared first on Links Medicus.
What is mucormycosis, the fungal infection affecting COVID patients in India?
What is mucormycosis, the fungal infection affecting COVID patients in India? – The Conversation Related: What Is ‘Black Fungus’? And Why Is It Spreading Among India’s COVID Patients? – NPR AND Mucormycosis: The ‘black fungus’ maiming Covid patients in India
The post What is mucormycosis, the fungal infection affecting COVID patients in India? appeared first on Links Medicus.
Review: How to interpret and use COVID-19 serology and immunology tests.
How to interpret and use COVID-19 serology and immunology tests – Clinical Microbiology and Infection
The post Review: How to interpret and use COVID-19 serology and immunology tests. appeared first on Links Medicus.
CDC says fully vaccinated Americans can go indoors and outdoors without masks.
CDC Guidance: Interim Public Health Recommendations for Fully Vaccinated People – Centers for Disease Control and Prevention Commentaries: CDC backtracks, saying fully vaccinated people can go maskless indoors – STAT AND Fully Vaccinated People Can Stop Wearing Masks Indoors And Outdoors, CDC Says – NPR AND CDC: No masks needed for COVID-vaccinated Americans – CIDRAP […]
The post CDC says fully vaccinated Americans can go indoors and outdoors without masks. appeared first on Links Medicus.
Editorial: Vaccinating children against SARS-CoV-2 – “Hard to justify right now for most children in most countries”.
Vaccinating children against SARS-CoV-2 – The BMJ Related: Pfizer COVID-19 shot expanded to US children as young as 12.
The post Editorial: Vaccinating children against SARS-CoV-2 – “Hard to justify right now for most children in most countries”. appeared first on Links Medicus.
Perspective | Vaccines seem to work well against coronavirus variants. It’s also complicated.
Vaccines seem to work well against coronavirus variants. It’s also complicated – STAT
The post Perspective | Vaccines seem to work well against coronavirus variants. It’s also complicated. appeared first on Links Medicus.
Perspective | New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications.
New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications – New England Journal of Medicine
The post Perspective | New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications. appeared first on Links Medicus.
RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects.
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data – The Lancet Commentaries: More side effects noted after using 2 different COVID vaccines – CIDRAP AND Covid vaccines: Mixing increases reports of mild side-effects – BBC
The post RCT: Mixing 2 different Covid vaccines is associated with increased risk of side effects. appeared first on Links Medicus.
[Preprint] Observational study finds single-dose Johnson & Johnson vaccine is 76.7% effective in preventing SARS-CoV-2 infection
Real-World Effectiveness of Ad26.COV2.S Adenoviral Vector Vaccine for COVID-19 – The Lancet Commentary on Twitter One of the first studies to assess real-world effectiveness of the J&J 1-dose vaccine, matches Phase 3 clinical trial, at 77%https://t.co/3YgcML9YSh @MayoClinic @MayoClinicHS preprint pic.twitter.com/XOjQlUaHK2 — Eric Topol (@EricTopol) May 11, 2021
The post [Preprint] Observational study finds single-dose Johnson & Johnson vaccine is 76.7% effective in preventing SARS-CoV-2 infection appeared first on Links Medicus.